On August 28, 2018 Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported that Adelene Perkins, Infinity Pharmaceuticals’ Chief Executive Officer, and Lawrence Bloch, Infinity Pharmaceuticals’ President, will present at the following conferences (Press release, Infinity Pharmaceuticals, AUG 28, 2018, View Source [SID1234529119]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 20th Annual Global Investment Conferencein New York, NY on Wednesday September 5, 2018 at 1:45 p.m. ET

Wells Fargo Securities 2018 Healthcare Conference in Boston, MA on Thursday, September 6, 2018 at 1:55 p.m. ET

25th Annual BioCentury NewsMakers in the Biotech Industry in New York, NY on Friday, September 7, 2018 at 8:30 a.m. ET. Additionally, for those who will be attending BioCentury NewsMakers, Adelene Perkins will be participating in the lunch panel from 12:15 – 1:15 p.m. ET on "Investing In Hot Topics Areas" moderated by Simone Fishburn, BioCentury’s VP and Executive Editor.

A live webcast of the presentation for each of these conferences, excluding the BioCentury NewsMakers lunch panel discussion, will be available on the Investors/Media section of Infinity’s website at www.infi.com, and will be available for 30 days following the event.